Anagrelide
98%
- Product Code: 110371
CAS:
68475-42-3
| Molecular Weight: | 256.09 g./mol | Molecular Formula: | C₁₀H₇Cl₂N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00866794 | |
| Melting Point: | Boiling Point: | 376.5°C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C |
Product Description:
Anagrelide is primarily used to treat thrombocythemia, a condition characterized by an excessive production of platelets in the blood. By inhibiting the maturation of megakaryocytes, it effectively reduces platelet counts, thereby lowering the risk of thrombosis and bleeding complications associated with high platelet levels. It is particularly beneficial for patients with essential thrombocythemia who are at risk of developing blood clots or have a history of thrombotic events. The medication is often prescribed when other treatments, such as hydroxyurea, are not suitable or effective. Regular monitoring of blood counts is essential during treatment to ensure optimal dosing and to minimize potential side effects.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $299.43 |
+
-
|
| 0.005 | 10-20 days | $897.09 |
+
-
|
Anagrelide
Anagrelide is primarily used to treat thrombocythemia, a condition characterized by an excessive production of platelets in the blood. By inhibiting the maturation of megakaryocytes, it effectively reduces platelet counts, thereby lowering the risk of thrombosis and bleeding complications associated with high platelet levels. It is particularly beneficial for patients with essential thrombocythemia who are at risk of developing blood clots or have a history of thrombotic events. The medication is often prescribed when other treatments, such as hydroxyurea, are not suitable or effective. Regular monitoring of blood counts is essential during treatment to ensure optimal dosing and to minimize potential side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :